$4.23
-0.15[-3.42%]
At close: Apr 24
$4.23
0[0.00%]
After Hours: 6:23PM EDT
BioCryst Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioCryst Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | BCRX | Q1 | -$0.28 | -$0.20 | — | — | $68.78M | $86.45M | — | — | Get Alert |
02/26/2024 | AM | BCRX | Q4 | -$0.38 | -$0.24 | -$0.28 | -16.67% | $79.55M | $90.01M | $93.40M | 3.77% | Get Alert |
11/02/2023 | AM | BCRX | Q3 | -$0.23 | -$0.23 | -$0.19 | 17.39% | $75.83M | $85.95M | $86.74M | 0.92% | Get Alert |
08/03/2023 | AM | BCRX | Q2 | -$0.32 | -$0.25 | -$0.24 | 4.00% | $65.53M | $81.98M | $82.49M | 0.62% | Get Alert |
05/03/2023 | AM | BCRX | Q1 | -$0.40 | -$0.30 | -$0.28 | 6.67% | $49.92M | $71.68M | $68.78M | -4.05% | Get Alert |
02/21/2023 | AM | BCRX | Q4 | -$0.40 | -$0.17 | -$0.38 | -123.53% | $47.16M | $75.64M | $79.55M | 5.16% | Get Alert |
11/01/2022 | AM | BCRX | Q3 | -$0.33 | -$0.28 | -$0.23 | 17.86% | $40.99M | $75.23M | $75.83M | 0.79% | Get Alert |
08/04/2022 | AM | BCRX | Q2 | -$0.24 | -$0.34 | -$0.32 | 5.88% | $49.96M | $64.31M | $65.53M | 1.90% | Get Alert |
05/05/2022 | AM | BCRX | Q1 | -$0.36 | -$0.37 | -$0.40 | -8.11% | $19.06M | $51.36M | $49.92M | -2.80% | Get Alert |
02/23/2022 | AM | BCRX | Q4 | -$0.34 | -$0.30 | -$0.40 | -33.33% | $4.02M | $50.56M | $47.16M | -6.73% | Get Alert |
11/03/2021 | AM | BCRX | Q3 | -$0.26 | -$0.29 | -$0.33 | -13.79% | $6.10M | $39.38M | $40.99M | 4.10% | Get Alert |
08/05/2021 | AM | BCRX | Q2 | -$0.24 | -$0.24 | -$0.24 | 0.00% | $2.87M | $28.48M | $49.96M | 75.42% | Get Alert |
05/06/2021 | AM | BCRX | Q1 | -$0.24 | -$0.27 | -$0.36 | -33.33% | $4.82M | $8.89M | $19.06M | 114.39% | Get Alert |
02/25/2021 | AM | BCRX | Q4 | -$0.02 | -$0.25 | -$0.34 | -36.00% | $39.73M | $17.52M | $4.02M | -77.08% | Get Alert |
11/05/2020 | AM | BCRX | Q3 | -$0.34 | -$0.25 | -$0.26 | -4.00% | $1.77M | $3.60M | $6.10M | 69.50% | Get Alert |
08/06/2020 | AM | BCRX | Q2 | -$0.34 | -$0.25 | -$0.24 | 4.00% | $1.45M | $2.26M | $2.87M | 27.04% | Get Alert |
05/06/2020 | AM | BCRX | Q1 | -$0.28 | -$0.25 | -$0.24 | 4.00% | $5.89M | $4.29M | $4.82M | 12.42% | Get Alert |
03/05/2020 | AM | BCRX | Q4 | -$0.25 | -$0.26 | -$0.02 | 92.31% | $2.73M | $9.88M | $39.73M | 302.07% | Get Alert |
11/06/2019 | AM | BCRX | Q3 | -$0.28 | — | -$0.34 | — | $1.45M | — | $1.77M | — | Get Alert |
BioCryst Pharma (BCRX) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 26, 2024 for Q4.
The Actual EPS was $-0.28, which missed the estimate of $-0.24.
The Actual Revenue was $93.4M, which beat the estimate of $90M.
Browse earnings estimates, EPS, and revenue on all stocks.